Takeda in the U.S.

Takeda has a strong commitment to the U.S. with more than 5,000 employees, a significant R&D presence, Oncology and Vaccines headquarters and manufacturing capabilities.

The U.S. is home to a Takeda global R&D presence, the U.S. Business Unit, and two global specialty business units--Takeda Oncology and Takeda Vaccine. 

Takeda U.S. Business Unit is among the top 25 largest pharmaceutical companies in the U.S. Founded in 1998, as Takeda's largest business unit outside of Japan, the U.S. Business Unit has a strong presence in both specialty care and primary care, with dedicated efforts on neuroscience and gastroenterology therapeutic areas. Click here to read the Takeda U.S. Fact Sheet with details on Takeda's U.S. presence.